“We are extremely encouraged by the outcome of our meeting with FDA including the fact that, while acknowledging their feedback was preliminary, the agency did not dismiss sunRIZE outright on the basis of not meeting its primary endpoint,” said Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute.
Market Data 
Markets 
AI
